Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2025 and 2026.
-
Tight liquidity NBB
Cash and receivables cover 14 % of short-term debt in 2026; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2026
ISOMED from Gent, company number BE0428638149, closed financial year 2026 with a result of € -157,886 after tax. For that financial year ISOMED recorded a gross margin of € 302 and equity of € 1.8 million. Compared with financial year 2025, the result moved from € -196,645 to € -157,886. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2026.
€ 1.8 million
▼ 8% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -157,886
▲ 20 % less loss than in 2025
Profit after tax over the fiscal year.
€ 38,561
▼ 68% vs 2025
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -238,307.
People and assets in 2026
€ 156,630
▲ 119% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 10,962
▼ 78% vs 2025
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € -2,451 | € -2,917 | € -68,595 | € 302 | ▲ € 68,896 |
| Profit after taxes | € -75,328 | € -76,507 | € -196,645 | € -157,886 | ▲ € 38,758 |
| Equity | € 211,331 | € 2,137,391 | € 1,940,746 | € 1,782,860 | ▼ 8% |
| Total debts | € 1,125,704 | € 1,611,573 | € 1,684,647 | € 1,969,141 | ▲ 17% |
| Cash | € 5,148 | € 438,655 | € 121,551 | € 38,561 | ▼ 68% |
| Land & buildings | € 1,087,879 | € 3,062,750 | € 3,032,913 | € 2,981,003 | ▼ 2% |
| Retained profit | € 192,731 | € 116,224 | € -80,421 | € -238,307 | ▼ € 157,886 |
| Balance sheet total | € 1,609,216 | € 4,021,061 | € 3,889,725 | € 4,008,568 | ▲ 3% |
Key figures of ISOMED, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to ISOMED?
What happened at ISOMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 157,886. Source: NBB ↗
- Doris DE MEYER became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 75,328 loss in 2023 to € 157,886 loss in 2026.
Paid € 202 in corporate taxes since 2023.
Management
The stake of VAN HOORDE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ISOMEDBehind ISOMED is Doris DE MEYER. The shares are held by VAN HOORDE (91.6%). It owns 15.3% of C & D itself.
Directors
According to the 2026 annual accounts
since 2021
Shareholders
91.6%
Participations
15.3%
Establishments
Establishment units
Physical locations of this company
Kouter 7-A box 201
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0428.638.149
- VAT number
- BE 0428.638.149
- Registered office
- Kouter 7-A bus 201, 9000 Gent
- Names & denominations
- ISOMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 March 1986
- Peppol
- Not registered